Athersys CEO to Speak at the 2018 Brain Health Summit
29 janv. 2018 06h00 HE
|
Athersys, Inc.
CLEVELAND, Ohio, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will be a speaker and panelist at the 2018 Brain Health...
HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem® Treatment for Ischemic Stroke
15 nov. 2017 10h05 HE
|
Athersys, Inc.
CLEVELAND, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its study in Japan evaluating...
Athersys Reports Third Quarter 2017 Results
08 nov. 2017 16h03 HE
|
Athersys, Inc.
CLEVELAND, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended September 30, 2017. Highlights of the third quarter of...
Athersys and Nikon CeLL Innovation to Collaborate on MultiStem® Commercial Manufacturing in Japan
11 oct. 2017 06h00 HE
|
Athersys, Inc.
CLEVELAND, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has entered into a manufacturing services agreement with Nikon CeLL innovation Co., Ltd. (NCLi) for...
Athersys to Host Third Quarter Financial Results Call
09 oct. 2017 10h00 HE
|
Athersys, Inc.
CLEVELAND, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 8, 2017,...
Athersys to Present at 2017 Cell & Gene Meeting on the Mesa and Announces Regenerative Medicine Advanced Therapy (RMAT) Designation From FDA
05 oct. 2017 07h00 HE
|
Athersys, Inc.
CLEVELAND, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Robert W. Mays, Ph.D., Vice President, Regenerative Medicine and Head of Neuroscience Programs, will...
Athersys Reports Second Quarter 2017 Results
09 août 2017 16h05 HE
|
Athersys, Inc.
CLEVELAND, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended June 30, 2017. Highlights of the second quarter of 2017...
Athersys Reports Alignment of Key Regulators for Pivotal Registration Study in Stroke
07 août 2017 06h00 HE
|
Athersys, Inc.
MultiStem® stem cell technology receives Positive Opinion from European Medicines Agency Adds to Special Protocol Assessment and Fast Track designation in U.S., and Priority Review under Sakigake...
Athersys to Host Second Quarter Financial Results Call
10 juil. 2017 10h00 HE
|
Athersys, Inc.
CLEVELAND, July 10, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 9, 2017,...
Athersys Reports First Quarter 2017 Results
09 mai 2017 16h05 HE
|
Athersys, Inc.
Company announces Fast Track Designation by FDA for Stroke Program and other progress Management to host conference call at 4:30pm EDT todayCLEVELAND, May 09, 2017 (GLOBE NEWSWIRE) --...